Reduced-intensity Treatment May be Effective for Early Hodgkin’s Lymphoma (08/27/2010)
Among patients with early-stage Hodgkin’s lymphoma and a favorable prognosis, it may be possible to reduce the number of chemotherapy cycles and the dose of radiation therapy without adversely affecting outcome. The results of this study were published in the New England Journal of Medicine.

Study Confirms that Radiation Therapy Is Not Necessary in Patients with Favorable, Limited-stage Hodgkin’s Lymphoma (04/05/2010)
Researchers from the Dana-Farber Cancer Center have confirmed prior studies that indicate chemotherapy alone is safe and effective for the treatment of early-stage Hodgkin’s Lymphoma in appropriate patients. The details of this study were published in a recent issue of the Journal of Clinical Oncology.

Childhood Cancer Survivors Treated with Radiation Therapy at Increased Risk of Death from Heart Disease in Adulthood (03/26/2010)
A dose of as little as 5 Gy of radiation therapy to the heart for the treatment of childhood cancers results in a significant increase in cardiac death later in life, according to a study recently published in the Journal of Clinical Oncology.

Allogeneic Stem Cell Transplantation Viable for Children and Adolescents with Relapsed Hodgkin’s Lymphoma (09/24/2009)
Children and adolescents with relapsed Hodgkin’s lymphoma respond well to allogeneic stem cell transplantation, according to the results of a study published in Blood.

September Is National Leukemia and Lymphoma Awareness Month (08/28/2009)
As the month of September brings leukemia and lymphoma into focus, it’s time to increase public understanding of these diseases, including their prevalence, approaches to screening and prevention, treatment options, and resources that offer updated leukemia and lymphoma information throughout the year.

Hodgkin’s Survivors at Increased Risk of Stroke (06/24/2009)
Patients who have been treated with radiation therapy for Hodgkin’s lymphoma have an elevated risk of stroke. These results were published in the Journal of the National Cancer Institute.

Advanced Stage

Early Stage

Reduced-intensity Treatment May be Effective for Early Hodgkin’s Lymphoma (08/27/2010)
Among patients with early-stage Hodgkin’s lymphoma and a favorable prognosis, it may be possible to reduce the number of chemotherapy cycles and the dose of radiation therapy without adversely affecting outcome. The results of this study were published in the New England Journal of Medicine.

Progressive Relapsed